Asia Pacific Pharmacogenomics Market 2019-2025)

日付: June 30, 2019
ページ: 103
価格:
ドル1,500.00
ライセンス[?]:
出版社: KBVリサーチ
レポートの種類: 戦略レポート
配信: メール配信(PDF)
ID: A554A2C640FEN
リーフレット:

PDFリーフレットをダウンロードする

Asia Pacific Pharmacogenomics Market 2019-2025)
The Asia Pacific Pharmacogenomics Market would witness market growth of 10.2% CAGR during the forecast period (2019–2025).

The study of pharmacogenomics deals with the role of genes in drug response in individuals. The growing number of pharmacogenomics-based tests, which are a result of the growing ailments like cancer, tuberculosis, Alzheimer's disease, cardiovascular diseases, and other diseases, is expected to push the market growth. Pharmacogenomics has observed an exponential growth rate in recent years, owing to a rise in preference of patients towards personalized therapy-based medications.

The major factors boosting the growth of pharmacogenomics include technological advancements in molecular diagnostics, such as several molecular biology techniques including polymerase chain reaction, sequencing, microarrays, electrophoresis, mass spectrometry among others, a surge in the preference for using personalized therapy.

Based on Technology, the market is segmented into Sequencing, Polymerase Chain Reaction, Electrophoresis, Mass Spectrometry, Microarray and Others. Based on Application, the market is segmented into Oncology, Psychiatry, Infectious Diseases, Neurological Diseases, Pain management, Cardiovascular Diseases and Others. Based on End User, the market is segmented into Hospitals and Clinics, Research Institutions, and Academic Institutes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

市場調査レポートは、市場の主要な利害関係者の分析を網羅しています。 このレポートで紹介されている主要企業には、Abbott Laboratories、Empire Genomics LLC、Illumina、oneome LLC、Myriad Genetics Inc.、Thermo Fisher Scientific、Inc。、Teva Pharmaceuticals Industries Ltd.、Bayer AG、Opko Health、およびベクトン、ディキンソンアンドカンパニー。

研究の範囲

市場セグメンテーション:

アプリケーション別
  • シーケンス
  • ポリメラーゼ連鎖反応
  • 電気泳動
  • 質量分析
  • マイクロアレイ
  • 他人
アプリケーション別
  • 腫瘍学
  • 精神医学
  • 感染症
  • 神経疾患
  • 疼痛管理
  • 心血管疾患
  • 他人
エンドユーザー別
  • 病院と診療所
  • 研究機関
  • 学術機関
国別
  • 中国
  • 日本
  • インド
  • 韓国
  • Singapore
  • マレーシア
  • アジア太平洋地域の残りの部分
プロファイル会社
  • アボット·ラボラトリーズ
  • エンパイアゲノミクスLLC
  • イルミナ株式会社
  • オネームLLC
  • 無数の遺伝学株式会社
      • サーモフィッシャーサイエンティフィック社
  • テバ製薬工業株式会社
  • Bayer AG
      • 株式会社オプコヘルス
  • ベクトン、ディキンソンアンドカンパニー
章1 市場範囲および方法論

1.1マーケット定義
1.2の目的
1.3マーケットスコープ
1.4セグメンテーション
1.4.1 Asia Pacific Pharmacogenomics Market, by Application
1.4.2 Asia Pacific Pharmacogenomics Market, by Application
1.4.3 Asia Pacific Pharmacogenomics Market, by End User
1.4.4 Asia Pacific Pharmacogenomics Market, by Country
1.5研究のための方法論

章2 市場概況

2.1はじめに
2.1.1概要
2.1.2の市場構成とシナリオ
市場に影響を与える2.2の主な要因
2.2.1マーケットドライバー
2.2.2市場の制約

CHAPTER 3. ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY

3.1.1 Asia Pacific Sequencing Market by Country
3.1.2 Asia Pacific Polymerase Chain Reaction Market by Country
3.1.3 Asia Pacific Electrophoresis Market by Country
3.1.4 Asia Pacific Mass Spectrometry Market by Country
3.1.5 Asia Pacific Microarray Market by Country
3.1.6アジア太平洋地域の国別市場

CHAPTER 4. ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION

4.1.1 Asia Pacific Oncology Market by Country
4.1.2 Asia Pacific Psychiatry Market by Country
4.1.3 Asia Pacific Infectious Diseases Market by Country
4.1.4 Asia Pacific Neurological Diseases Market by Country
4.1.5 Asia Pacific Pain Management Market by Country
4.1.6 Asia Pacific Cardiovascular Diseases Market by Country
4.1.7アジア太平洋地域の国別市場

CHAPTER 5. ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER

5.1.1 Asia Pacific Hospitals and Clinics Market by Country
5.1.2 Asia Pacific Research Institutions Market by Country
5.1.3 Asia Pacific Academic Institutes Market by Country

CHAPTER 6. ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY

6.1 China Pharmacogenomics Market
6.1.1 China Pharmacogenomics Market by Technology
6.1.2 China Pharmacogenomics Market by Application
6.1.3 China Pharmacogenomics Market by End User
6.2 Japan Pharmacogenomics Market
6.2.1 Japan Pharmacogenomics Market by Technology
6.2.2 Japan Pharmacogenomics Market by Application
6.2.3 Japan Pharmacogenomics Market by End User
6.3 India Pharmacogenomics Market
6.3.1 India Pharmacogenomics Market by Technology
6.3.2 India Pharmacogenomics Market by Application
6.3.3 India Pharmacogenomics Market by End User
6.4 South Korea Pharmacogenomics Market
6.4.1 South Korea Pharmacogenomics Market by Technology
6.4.2 South Korea Pharmacogenomics Market by Application
6.4.3 South Korea Pharmacogenomics Market by End User
6.5 Singapore Pharmacogenomics Market
6.5.1 Singapore Pharmacogenomics Market by Technology
6.5.2 Singapore Pharmacogenomics Market by Application
6.5.3 Singapore Pharmacogenomics Market by End User
6.6 Malaysia Pharmacogenomics Market
6.6.1 Malaysia Pharmacogenomics Market by Technology
6.6.2 Malaysia Pharmacogenomics Market by Application
6.6.3 Malaysia Pharmacogenomics Market by End User
6.7 Rest of Asia Pacific Pharmacogenomics Market
6.7.1 Rest of Asia Pacific Pharmacogenomics Market by Technology
6.7.2 Rest of Asia Pacific Pharmacogenomics Market by Application
6.7.3 Rest of Asia Pacific Pharmacogenomics Market by End User

章7 会社のプロフィール

7.1アボットラボラトリーズ
7.1.1会社の概要
7.1.2財務分析
7.1.3セグメント別および地域別分析
7.1.4研究開発費
7.1.5最近の戦略と開発:
7.1.5.1コラボレーション、パートナーシップおよび契約
7.1.5.2製品が発売されます。
7.1.5.3の買収と合併
7.1.6 SWOT分析
7.2エンパイアゲノミクスLLC
7.2.1会社の概要
7.3イルミナ株式会社
7.3.1会社の概要
7.3.2財務分析
7.3.3地域別およびセグメント分析
7.3.4研究開発費
7.3.5最近の戦略と開発:
7.3.5.1コラボレーション、パートナーシップおよび契約
7.3.5.2製品が発売されます。
7.3.5.3の買収と合併
7.4 OneOme LLC
7.4.1会社の概要
7.5 Myriad Genetics Inc.
7.5.1会社の概要
7.5.2財務分析
7.5.3セグメント別および地域別分析
7.5.4研究開発費
7.5.5最近の戦略と開発:
7.5.5.1コラボレーション、パートナーシップおよび契約
7.5.5.2製品が発売されます。
7.6サーモフィッシャーサイエンティフィック社
7.6.1会社の概要
7.6.2財務分析
7.6.3セグメント別および地域別分析
7.6.4研究開発費
7.6.5最近の戦略と開発:
7.6.5.1コラボレーション、パートナーシップおよび契約
7.6.5.2の買収と合併
7.6.6 SWOT分析
7.7テバ製薬工業株式会社
7.7.1会社の概要
7.7.2財務分析
7.7.3セグメント分析
7.7.4研究開発費
7.7.5最近の戦略と開発:
7.7.5.1製品が発売されます。
7.8バイエル社
7.8.1会社の概要
7.8.2財務分析
7.8.3セグメント別および地域別分析
7.8.4研究開発費
7.8.5最近の戦略と開発:
7.8.5.1コラボレーション、パートナーシップおよび契約
7.8.6 SWOT分析
7.9オプコヘルス株式会社(GeneDx、Inc.)
7.9.1会社の概要
7.9.2財務分析
7.9.3研究開発費
7.9.4最近の戦略と開発:
7.9.4.1コラボレーション、パートナーシップおよび契約
7.9.4.2製品が発売されます。
7.1ベクトン、ディキンソンアンドカンパニー
7.10.1会社の概要
7.10.2財務分析
7.10.3セグメント別および地域別分析
7.10.4研究開発費
7.10.5最近の戦略と開発:
7.10.5.1コラボレーション、パートナーシップおよび契約
7.10.5.2の買収と合併
7.10.5.3製品が発売されます。
7.10.6 SWOT分析

表のリスト

TABLE 1 ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 3 ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 4 ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 5 ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 ASIA PACIFIC SEQUENCING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC POLYMERASE CHAIN REACTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC ELECTROPHORESIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC MASS SPECTROMETRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC MICROARRAY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
国別15アジア太平洋地域の市場、2015-2018、USDミリオン
国別16アジア太平洋地域の市場、2019-2025、USDミリオン
TABLE 17 ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC ONCOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC PSYCHIATRY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC INFECTIOUS DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC NEUROLOGICAL DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC PAIN MANAGEMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC CARDIOVASCULAR DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
国別31アジア太平洋地域の市場、2015-2018、USDミリオン
国別32アジア太平洋地域の市場、2019-2025、USDミリオン
TABLE 33 ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 35 ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 ASIA PACIFIC HOSPITALS AND CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 38 ASIA PACIFIC RESEARCH INSTITUTIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 39 ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 40 ASIA PACIFIC ACADEMIC INSTITUTES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 41 ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 42 ASIA PACIFIC PHARMACOGENOMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 43 CHINA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 44 CHINA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 45 CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 46 CHINA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 47 CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 48 CHINA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 49 CHINA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 50 CHINA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 51 JAPAN PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 52 JAPAN PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 53 JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 54 JAPAN PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 55 JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 JAPAN PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 JAPAN PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 58 JAPAN PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 59 INDIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 60 INDIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 61 INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 62 INDIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 63 INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 64 INDIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 65 INDIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 66 INDIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 67 SOUTH KOREA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 68 SOUTH KOREA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 69 SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 70 SOUTH KOREA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 71 SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 72 SOUTH KOREA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 73 SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 74 SOUTH KOREA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 75 SINGAPORE PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 76 SINGAPORE PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 77 SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 78 SINGAPORE PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 79 SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 80 SINGAPORE PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 81 SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 82 SINGAPORE PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 83 MALAYSIA PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 84 MALAYSIA PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 85 MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 86 MALAYSIA PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 87 MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 88 MALAYSIA PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 89 MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 90 MALAYSIA PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
TABLE 91 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2015 - 2018, USD MILLION
TABLE 92 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET, 2019 - 2025, USD MILLION
TABLE 93 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 94 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 95 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 96 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 97 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2015 - 2018, USD MILLION
TABLE 98 REST OF ASIA PACIFIC PHARMACOGENOMICS MARKET BY END USER, 2019 - 2025, USD MILLION
表99の主要情報 - アボットラボラトリー
表100の主な情報-EMPIRE GENOMICS LLC
表101の主な情報–イルミナ
表102の主な情報– ONEOME LLC
表103の主な情報–ミリアドジェネティックス
表104の主な情報-THERMO FISHER SCIENTIFIC、INC。
表105の主な情報-TEVA PHARMACEUTICALS INDUSTRIES LTD。
表106の主な情報–バイエルAG
表107の主要情報-OPKO HEALTH、INC。
表108の主な情報-BECTON、DICKINSONおよびCOMPANY

図の目次

研究のためのFIG 1方法論
FIG 2 SWOT分析:ABBOTT LABORATORIES
FIG 3 SWOT分析:THERMO FISHER SCIENTIFIC、INC。
FIG 4 SWOT分析:バイエルAG
FIG 5 SWOT分析:BECTON、DICKINSONおよびCOMPANY
トップへスキップ


あなたの質問をする

Asia Pacific Pharmacogenomics Market 2019-2025)
会社名*:
連絡窓口*:
電話/ファックス*:
Eメール*:
請求書を要求する
お問い合わせ:
下のチェックボックスをクリックして、あなたがロボットではないことを確認してください。